|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Activity of SUl1248, a muhitargeted inhibitor of vascular endothelial growth faclor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma 显示文摘 | Motzer R J Michaelson MD Redman BG | 2006 | J Clin Oncol2006，24，1： | 1 |
| 2 | Sunitinib efficacy against advanced renal cell carcinoma 显示文摘 | Motzer R J Michaelson MD Rosenberg J | 2007 | J Urol2007，178，5： | 1 |
| 3 | Axltinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study 显示文摘 | RIXE O BUKOWSKI RM MICHAELSON MD | 2007 | Lancet Oncol2007，8，11： | 1 |
| 4 | Efficacy and safety of sunidnib malate (SU11248) in bevacizumab-refractory metastatic renal cell carcinoma (mRCC)显示文摘 | Rini BI George DJ Michaelson MD | 2006 | J Clin Oncol2006，24，18： | 1 |
| 5 | Activity of SUl1248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor re- ceptor, in patients with metastatic renal cell carcinoma 显示文摘 | Motzer R J Michaelson MD Redman BG | 2006 | J Clin Oncol2006，24，1： | 1 |
| 6 | Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer:a phase Ⅱ study显示文摘 | Rixe O Bukowski RM Michaelson MD | 2007 | Lancet Oncol2007，8，11： | 1 |
| 7 | Retinal ischemia leads to apoptosis which is ameliorated by aurintricarboxylic acid显示文摘 | Rosenbaum DM Rosenbaum PS Gupta A Michaelson MD Hall DH Kessler JA | 1997 | Vision Res1997，37，24： | 1 |
| 8 | Activity of SU11248,a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor,in patients with metastatic renal cell carcinoma显示文摘 | Motzer RJ Michaelson MD Redman BG | 2006 | Journal of Clinical Oncology2006，，01： | 1 |
| 9 | Exposure-response of sunitinib in metastatic renal cell carcinoma ( mRCC) : A popu-lalion pharmacokinetic/pharmacodyna-mic( PKPD) approach显示文摘 | Houk BE Bello CL Michaelson MD | 2007 | J Clin Oncol2007，25，18： | 1 |
| 10 | Sunitinib efficacy against advanced renal cell carcinoma显示文摘 | Motzer RJ Michaelson MD Rosenberg J | 2007 | Journal of Urology2007，，05： | 1 |
| 11 | Sunitinib efficacy against advanced renal cell carcinoma 显示文摘 | MOTZER RJ MICHAELSON MD ROSENBERG J | 2007 | J Urol2007，178，5： | 1 |
| 12 | Activity of SU 11248, a muhitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in pa- tients with metastatic renal cell cawinoma 显示文摘 | Motzer RJ Michaelson MD Redman BG | 2007 | J Clin Oncol2007，24，1： | 1 |
| 13 | Sunitinib efficacy against advanced renal cell carcinoma显示文摘 | Motzer RJ Michaelson MD Rosenberg J | 2007 | J Urol2007，178，5： | 1 |
| 14 | A Phase I study of 9-nitrocamptothecin given concurrently with capecitabine in patients with refractory,metastatic solid tumors显示文摘 | MICHAELSON MD RYAN DP FUCHS CS | 2003 | Cancer2003，97，1： | 1 |
| 15 | Randomized phaseⅡstudy of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer显示文摘 | MICHAELSON MD KAUFMAN DS KANTOFF P | 2006 | Cancer2006，107，3： | 1 |
| 16 | Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma 显示文摘 | Motzer RJ Michaelson MD Redman BG | 2006 | J Clin Oncol2006，24，1： | 1 |
| 17 | A phase I study of 9-Nitrocamptothecin given concurrently with capecitabine in patients with refractory, metastatic solid tumors 显示文摘 | Michaelson MD Ryan DP Fuchs CS | 2003 | Cancer2003，97，1： | 1 |
| 18 | Axitinib treatment in patients with eytokine-refractory metastatic renal cell cancer:a phase Ⅱ study显示文摘 | Rixe O Bukowski RM Michaelson MD | 2007 | Lancet Oncol2007，8，11： | 1 |
| 19 | Axitinib treatment in patients with cytokine-refractory metastatic renal cell cancer:a phase II study 显示文摘 | Rixe O Bukowski RM Michaelson MD | 2007 | Lancet Onto12007，8，11： | 1 |
| 20 | Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet -derived rowth factor receptor in patients with metastatic renal cell carcinoma显示文摘 | Motzer RJ Michaelson MD Redman BG | 2006 | J Clin Oncol2006，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员